Spire Healthcare Group — Form 8 (DD) - Spire Healthcare Group Plc

Bridgemere Securities sold all 22.4 million Spire shares at 245p each, exiting its position.

What the company is saying

The disclosure reports that Bridgemere Securities Limited, acting in concert with the Offeror, sold 22,435,739 1p Ordinary shares in Spire Healthcare Group Plc at 245p per share on 8 September 2026. The filing states that, following this transaction, Bridgemere Securities Limited holds zero interests and zero short positions in Spire Healthcare Group Plc. The announcement explicitly confirms there are no remaining derivative positions, rights to subscribe, indemnity arrangements, or related agreements. The tone is strictly factual and procedural, with no commentary on the rationale for the sale or its implications for Spire Healthcare Group Plc. The only named individual is Nicole Burstow, listed as the contact for the disclosure, with no further detail on her role. The company provides no explanation for the timing or motivation behind the transaction.

What the data suggests

The data confirms a complete divestment by Bridgemere Securities Limited of its entire holding in Spire Healthcare Group Plc, totaling 22,435,739 shares at a price of 245p per share. This transaction occurred on 8 September 2026, with the disclosure made public on 11 September 2026. The sale leaves Bridgemere Securities Limited with no remaining shares or short positions in Spire. No derivatives, options, or rights to subscribe remain open, and there are no outstanding agreements or collateral arrangements. The disclosure is comprehensive for regulatory purposes but offers no insight into the broader ownership structure, the identity of the buyer, or any strategic consequences for Spire Healthcare Group Plc. There are no financial performance metrics, operational updates, or forward-looking statements included.

Analysis

The announcement is a routine regulatory disclosure of a significant share sale by Bridgemere Securities Limited in Spire Healthcare Group Plc. All claims are factual, past-tense, and fully supported by specific numerical data (number of shares, price, resulting positions). There are no forward-looking statements, projections, or promotional language. No capital outlay, operational plans, or financial performance metrics are discussed. The tone is strictly neutral and procedural, with no attempt to frame the transaction as positive or negative for investors. This is a standard Form 8 (DD) filing required under the UK Takeover Code, and contains no narrative inflation or exaggeration.

Risk flags

• ●The exit of Bridgemere Securities Limited from its entire position in Spire Healthcare Group Plc could signal a shift in the shareholder base, potentially affecting future voting dynamics or takeover outcomes if an offer is underway.
• ●The absence of any disclosed rationale or context for the sale leaves investors without information on whether this move reflects a change in confidence, a response to external events, or other strategic considerations.
• ●No information is provided about the buyer or the resulting distribution of shares, creating uncertainty about whether the shares have moved to a strategic holder or into the market, which could affect liquidity or control.

Bottom line

This filing documents that Bridgemere Securities Limited has fully exited its position in Spire Healthcare Group Plc, selling 22,435,739 shares at 245p each on 8 September 2026. The disclosure is strictly regulatory, providing no commentary on the reasons for the sale or its impact on Spire's ownership or strategy. Investors are left without insight into whether this move reflects a broader shift in sentiment or is part of an ongoing takeover process. The lack of detail on the buyer and the absence of any forward-looking statements mean the practical impact remains unclear. For now, the most important takeaway is that a major shareholder has divested completely, and any implications for Spire's control or future direction will depend on subsequent disclosures.

Announcement summary

(LSE:SPI) Bridgemere Securities Limited, acting in concert with the Offeror, disclosed a sale of 22,435,739 1p Ordinary shares of Spire Healthcare Group Plc at a price of 245p per unit on 8 September 2026. Following this transaction, Bridgemere Securities Limited holds 0 interests and 0 short positions in the relevant securities of Spire Healthcare Group Plc. No cash-settled or stock-settled derivative positions, agreements to purchase or sell, or rights to subscribe for new securities were disclosed. There are no indemnity or other dealing arrangements, nor any agreements, arrangements, or understandings relating to options or derivatives. No Supplemental Forms 8 (Open Positions) or 8 (SBL) are attached. The disclosure was made on 11 September 2026 by Nicole Burstow.

Disagree with this article?